ROCHESTER — Mayo Clinic has added a magnetic nanoparticle-mediated hyperthermia machine to its cancer treatment lineup in Rochester, becoming the first in the U.S. to install that technology.

Mayo Clinic collaborated with New Phase Ltd. to install the first magnetic nanoparticle-mediated hyperthermia machine for ...

Palliative care that recognizes patient goals and values is essential, starting at diagnos ...

Luciano Costa waited three years to see how patients with an aggressive bone-marrow cancer would fare on an experimental immunotherapy treatment. Reviewing the results gave him goose bumps. “Holy shit ...

Stage 3 multiple myeloma is defined by high beta-2 microglobulin, elevated LDH, and high-risk genetic abnormalities. Diagnosis involves CRAB criteria and tests like bone marrow biopsy, imaging, and ...

ROCHESTER, Minn. — A recent study by Mayo Clinic published in the New England Journal of Medicine has revealed promising results for treating extramedullary multiple myeloma using a dual-antibody ...

ROCHESTER, Minn. — A new Mayo Clinic study published in the New England Journal of Medicine has uncovered that an off-the-shelf, dual-antibody therapy can generate deep and durable responses in ...

GE HealthCare and the Mayo Clinic are expanding their long-running collaborative work to now include the development of new personalized radiation therapy approaches for cancer, with a plan to bring ...

MONDAY, Nov. 24, 2025 (HealthDay News) -- Patients with newly diagnosed multiple myeloma (NDMM) treated at a specialized clinic have improved outcomes, with median overall survival (OS) of 152 months, ...

KCCI EIGHT NEWS AT TEN STARTS NOW. UNITYPOINT HEALTH DOCTORS MAY BE ABLE TO IMPROVE PATIENT CARE WITH A NEW ARTIFICIAL INTELLIGENCE PROGRAM. IT’S PART OF A COLLABORATION BETWEEN THE HOSPITAL NETWORK ...

Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...

A team of Mayo Clinic scientists have created a way to estimate a person’s risk of developing memory and thinking problems long before symptoms of Alzheimer’s disease begin, potentially changing how ...